Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -36.33% is 83% above its 5-year average of -207.88%, near the high end of its 5-year range (-561.65%–-25.92%).
32.66% below its 12-month average of -27.39%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -13.62%.
RETURN ON ASSETS (ROA)
-36.33%
RETURN ON ASSETS (ROA) AVG TTM
-27.39%
RETURN ON ASSETS (ROA) AVG 3Y
-256.74%
RETURN ON ASSETS (ROA) AVG 5Y
-207.88%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-32.66%
CURRENT VS 3Y AVG
+85.85%
CURRENT VS 5Y AVG
+82.52%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-27.69%
median of 556 covered companies
CURRENT VS SECTOR MEDIAN
-31.23%
vs the sector median at left
Alpha Cognition Inc
Market Cap
$139.63M
Return on Assets (ROA)
-36.33%
TTM Avg
-27.39%
3Y Avg
-256.74%
5Y Avg
-207.88%
Market Cap
$145.39M
Return on Assets (ROA)
-28.35%
TTM Avg
-69.97%
3Y Avg
-58.34%
5Y Avg
-49.63%
Market Cap
$146.95M
Return on Assets (ROA)
-96.78%
TTM Avg
-33.63%
3Y Avg
-87.61%
5Y Avg
-84.15%
Market Cap
$148.07M
Return on Assets (ROA)
-90.55%
TTM Avg
-70.80%
3Y Avg
-45.07%
5Y Avg
-40.08%
Market Cap
$141.70M
Return on Assets (ROA)
35.31%
TTM Avg
-14.11%
3Y Avg
-23.46%
5Y Avg
-20.68%
Market Cap
$141.09M
Return on Assets (ROA)
-6.07%
TTM Avg
-5.08%
3Y Avg
-4.92%
5Y Avg
-1.70%
Market Cap
$154.76M
Return on Assets (ROA)
-25.59%
TTM Avg
-36.78%
3Y Avg
-35.70%
5Y Avg
-27.05%
Market Cap
$153.56M
Return on Assets (ROA)
-35.50%
TTM Avg
-18.07%
3Y Avg
-62.20%
5Y Avg
-134.72%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Cognition Inc (ACOG) | $139.63M | -36.33% | -27.39% | -256.74% | -207.88% |
| Immuneering Corporation (IMRX)vs › | $145.39M | -28.35% | -69.97% | -58.34% | -49.63% |
| Korsana Biosciences, Inc. (KRSA)vs › | $146.95M | -96.78% | -33.63% | -87.61% | -84.15% |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $148.07M | -90.55% | -70.80% | -45.07% | -40.08% |
| Fortress Biotech, Inc. (FBIOP)vs › | $141.70M | 35.31% | -14.11% | -23.46% | -20.68% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $141.09M | -6.07% | -5.08% | -4.92% | -1.70% |
| Codexis, Inc. (CDXS)vs › | $154.76M | -25.59% | -36.78% | -35.70% | -27.05% |
| LifeMD, Inc. (LFMDP)vs › | $153.56M | -35.50% | -18.07% | -62.20% | -134.72% |
| Freenome, Inc. (FRNM)vs › | $138.31M | N/A | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $155.62M | -127.14% | -129.15% | -91.50% | -82.73% |
ROA
-36.3%
ROE
-44.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -25.92% |
| 2024-12-31 | -28.85% |
| 2023-12-31 | -561.65% |
| 2022-12-31 | -410.54% |
| 2021-12-31 | -151.74% |
| 2020-12-31 | -68.56% |
| 2019-07-31 | 0.00% |
| 2018-07-31 | 0.00% |
